Cannabis SPAC Achari Ventures I Pushes Shareholder Meeting Back 2 Days 

Achari Ventures Holdings I today announced that its stockholders meeting originally scheduled for today was adjourned and will recommence Dec. 22.

The SPAC is asking shareholders to vote on a three-months deadline extension, from Jan. 19, 2023 to April 19 or up to to six months to July 19, with extensions exercisable in single-month increments. 

The share redemption deadline in connection with the extension proposal was pushed back to Dec. 20 at 5 p.m. Eastern.

Achari raised $100 million in an October 2021 IPO. The company’s initial focus was to be on identifying acquisition opportunities with an ancillary business operating in the cannabis industry, including equipment, hardware, technology/software, or hydroponics. Read more.

Total
0
Shares
Related Posts
Read More

Phoenix Biotech Receives Nasdaq Warning

Phoenix in June signed a merger agreement with CERo Therapeutics at a pro forma equity capitalization of $145 million. The target is an immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms.